Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04435912Phase 1Completed
Phase 1, randomised, double-blind trial of hydrocortisone in hypotension (2 arms), sponsored by University of Jordan. Primary endpoint: Systolic, Diastolic, and Mean Arterial Pressure at 30 months. Started Jul 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04435912.